Binge drug use independently predicts HIV seroconversion among injection drug users: Implications for public health strategies

Substance Use and Misuse

Volumn 41, Issue 2, 2006, Pages 199-210

  Miller, Cari L ^a,b   Kerr, Thomas ^a,b,c,d   Frankish, James C ^b,d   Spittal, Patricia M ^a,b,e   Li, Kathy ^a   Schechter, Martin T ^a,b,c,d,f,g   Wood, Evan ^a,b,c,d  

^a ST PAUL S HOSPITAL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c BRITISH COLUMBIA CENTRE FOR EXCELLENCE IN HIV AIDS   (Canada)

^d University of British Columbia ^*

^e Cedars Project   (United Kingdom)

^f Canadian HIV Trials Network   (Canada)

^g CENTRE FOR HEALTH EVALUATION AND OUTCOME SCIENCES   (Canada)

Author keywords

Binge drug use; HIV transmission; Injection drug use; Protective factors; Public health; Vulnerability

Indexed keywords

COCAINE; DIAMORPHINE; METHADONE;

ADULT; ARTICLE; COHORT ANALYSIS; CONFIDENCE INTERVAL; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEALTH HAZARD; HIGH RISK BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INTRAVENOUS DRUG ABUSE; MALE; METHADONE TREATMENT; MODEL; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PUBLIC HEALTH; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTOR; SEROCONVERSION; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; SYRINGE;

BRITISH COLUMBIA; COHORT STUDIES; FEMALE; HIV SEROPOSITIVITY; HUMANS; MALE; PROSPECTIVE STUDIES; PUBLIC HEALTH PRACTICE; QUESTIONNAIRES; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 30344453045     PISSN: 10826084     EISSN: 15322491     Source Type: Journal    
DOI: 10.1080/10826080500391795     Document Type: Article

References (35)

1. Archibald, C. P., Ofner, M., Strathdee, S. A., et al. (1998). Factors associated with frequent needle exchange program attendance in injection drug users in Vancouver, Canada. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology 17(2):160-166.
2. Battjes, R. J., Pickens, R. W., Haverkos, H. W., et al. (1994). HIV risk factors among injecting drug users in five US cities. AIDS 8(5):681-687.
3. Bluthenthal, R. N., Kral, A. H., Erringer, E. A., et al. (1998). Use of an illegal syringe exchange and injection-related risk behaviors among street-recruited injection drug users in Oakland, California, 1992 to 1995. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology 18(5):505-511.
4. Chaisson, R. E., Bacchetti, P., Osmond, D., et al. (1989). Cocaine use and HIV infection in intravenous drug users in San Francisco. [comment]. Journal of American Medical Association 261(4):561-565.
5. Craib, K. J., Spittal, P. M., Wood, E., et al. (2003). Risk factors for elevated HIV incidence among Aboriginal injection drug users in Vancouver [comment]. CMAJ Canadian Medical Association Journal 168(1):19-24.
6. De Irala, J., Bigelow, C., McCusker, J., et al. (1996). Reliability of self-reported human immunodeficiency virus risk behaviors in a residential drug treatment population. American Journal of Epidemiology 143(7):725-732.
7. de Vos, J. W., Ufkes, J. G., van Brussel, G. H., et al. (1996). Craving despite extremely high methadone dosage. Drug & Alcohol Dependence 40(3):181-184.
8. Des Jarlais, D. C., Marmor, M., Paone, D., et al. (1996). HIV incidence among injecting drug users in New York City syringe-exchange programmes. Lancet 348(9033):987-991.
9. Diggle, P., Liang, K., Zeger, S. (1996). Analysis of Longitudinal Data. Cambridge: Oxford University Press.
10. Dolan, K. A., Wodak, A. (1999). HIV transmission in a prison system in an Australian State. [comment]. Medical Journal of Australia 171(1):14-17.
11. Drucker, E., Lurie, P., Wodak, A., et al. (1998). Measuring harm reduction: the effects of needle and syringe exchange programs and methadone maintenance on the ecology of HIV. AIDS 12(Suppl. A):S217-S230.
12. Estebanez, P. E., Russell, N. K., Aguilar, M. D., et al. (2000). Women, drugs and HIV/AIDS: results of a multicentre European study. International Journal of Epidemiology 29(4):734-743.
13. Fischer, B., Rehm, J., Kirst, M., et al. (2002). Heroin-assisted treatment as a response to the public health problem of opiate dependence. [comment]. European Journal of Public Health 12(3):228-234.
14. Fuller, C. M., Vlahov, D., Latkin, C. A., et al. (2003). Social circumstances of initiation of injection drug use and early shooting gallery attendance: implications for HIV intervention among adolescent and young adult injection drug users. Journal of Acquired Immune Deficiency Syndromes: JAIDS 32(1):86-93.
15. Guadagnino, V., Zimatore, G., Izzi, A., et al. (1995). Relevance of intravenous cocaine use in relation to prevalence of HIV, hepatitis B and C virus markers among intravenous drug abusers in southern Italy. Journal of Clinical & Laboratory Immunology 47(1):1-9.
16. Hagan, H., Jarlais, D. C., Friedman, S. R., et al. (1995). Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program. [comment]. American Journal of Public Health 85(11):1531-1537.
17. Kerr, T., Wood, E., Small, D., et al. (2003). Potential use of safer injection facilities among injection drug users in Vancouver's Downtown Eastside. CMAJ 169(8):Oct 14, 2003.
18. Lamothe, F., Bruneau, J., Soto, J., et al. (1992). Increasing prevalence of HIV-1 infection among injection drug users in Montréal. Canadian Communicable Disease Report 18:98-101.
19. McLellan, A., Arndt, I., Metzger, D., et al. (1993). The effects of psychosocial services in substance abuse treatment. Journal of American Medical Association 269:1953-1959.
20. Miller, C. L., Johnston, C., Spittal, P. M., et al. (2002). Opportunities for prevention: hepatitis C prevalence and incidence in a cohort of young injection drug users. Hepatology 36(3):737-742.
21. Perneger, T. V., Giner, F., del Rio, M., et al. (1998). Randomised trial of heroin maintenance programme for addicts who fail in conventional drug treatments. BMJ 317(7150):13-18.
22. Rothon, D. A., Mathias, R. G., Schechter, M. T. (1994). Prevalence of HIV infection in provincial prisons in British Columbia. [comment]. CMAJ Canadian Medical Association Journal 151(6):781-787.
23. Spittal, P., Small, W., Wood, E., et al. (2003a). How otherwise dedicated AIDS prevention workers come to support state-sponsored shortage of clean syringes in Vancouver, Canada. International Journal of Drug Policy. In press.
24. Spittal, P. M., Bruneau, J., Craib, K. J., et al. (2003b). Surviving the sex trade: a comparison of HIV risk behaviors among street-involved women in two Canadian cities who inject drugs. AIDS Care 15(2):187-195.
25. Spittal, P. M., Craib, K. J., Wood, E., et al. (2002). Risk factors for elevated HIV incidence rates among female injection drug users in Vancouver. CMAJ Canadian Medical Association Journal 166(7):894-899.
26. Strathdee, S. A., Patrick, D. M., Archibald, C. P., et al. (1997a). Social determinants predict needle-sharing behavior among injection drug users in Vancouver, Canada. Addiction 92(10):1339-1347.
27. Strathdee, S. A., Patrick, D. M., Currie, S. L., et al. (1997b). Needle exchange is not enough: lessons from the Vancouver injecting drug use study. AIDS 11(8):F59-F65.
28. Tyndall, M. W., Currie, S., Spittal, P., et al. (2003). Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic.[comment]. AIDS 17(6):887-893.
29. van den Brink, W., Hendriks, V. M., Blanken, P., et al. (2003). Medical prescription of heroin to treatment resistant heroin addicts: two randomised controlled trials. BMJ 327(7410):310.
30. Vlahov, D., Des Jarlais, D. C., Goosby, E., et al. (2001). Needle exchange programs for the prevention of human immunodeficiency virus infection: epidemiology and policy. American Journal of Epidemiology 154(Suppl. 12):S70-S77.
31. Watters, J. K., Estilo, M. J., Clark, G. L., et al. (1994). Syringe and needle exchange as HIV/AIDS prevention for injection drug users. [comment]. Journal of American Medical Association 271(2):115-120.
32. Wood, E., Kerr, T., Spittal, P. M., et al. (2003a). The potential public health and community impacts of safer injecting facilities: evidence from a cohort of injection drug users. Journal of Acquired Immune Deficiency Syndromes: JAIDS 32(1):2-8.
33. Wood, E., Small, W., Spittal, P., et al. (2003b). Do unsafe injection practices explain the association between HIV infection and incarceration among injection drug users? Journal of Infectious Disease. In press.
34. Wood, E., Tyndall, M. W., Spittal, P. M., et al. (2002). Factors associated with persistent high-risk syringe sharing in the presence of an established needle exchange programme. AIDS 16(6):941-943.
35. Zaric, G., Barnett, P., Brandeau, M., et al. (2000). HIV transmission and the cost-effectiveness of methadone maintenance. American Journal of Public Health 90:1100-1111.